The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...
DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.
In patients with persistent AF who underwent cardioversion, a cup of joe per day lowered the risk of recurrences at 6 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback